BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 26255745)

  • 1. Management of breast cancer in very young women.
    Rosenberg SM; Partridge AH
    Breast; 2015 Nov; 24 Suppl 2():S154-8. PubMed ID: 26255745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of breast cancer in very young women.
    Freedman RA; Partridge AH
    Breast; 2013 Aug; 22 Suppl 2():S176-9. PubMed ID: 24074783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.
    Jankowitz RC; McGuire KP; Davidson NE
    Breast; 2013 Aug; 22 Suppl 2():S165-70. PubMed ID: 24074781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant endocrine therapy for premenopausal women with hormone-responsive breast cancer.
    Mathew A; Davidson NE
    Breast; 2015 Nov; 24 Suppl 2():S120-5. PubMed ID: 26255743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of breast cancer in countries with limited resources.
    Carlson RW; Anderson BO; Chopra R; Eniu AE; Jakesz R; Love RR; Masetti R; Schwartsmann G;
    Breast J; 2003; 9 Suppl 2():S67-74. PubMed ID: 12713499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal adjuvant therapy for very young breast cancer patients.
    Francis PA
    Breast; 2011 Aug; 20(4):297-302. PubMed ID: 21605976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.
    Lambertini M; Del Mastro L; Viglietti G; Pondé NF; Solinas C; de Azambuja E
    Curr Treat Options Oncol; 2017 Jan; 18(1):4. PubMed ID: 28185173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and therapy of premenopausal patients with early-onset breast cancer in Germany.
    Banz-Jansen C; Heinrichs A; Hedderich M; Waldmann A; Dittmer C; Wedel B; Mebes I; Diedrich K; Fischer D
    Arch Gynecol Obstet; 2012 Aug; 286(2):489-93. PubMed ID: 22491806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer under age 40: a different approach.
    Ribnikar D; Ribeiro JM; Pinto D; Sousa B; Pinto AC; Gomes E; Moser EC; Cardoso MJ; Cardoso F
    Curr Treat Options Oncol; 2015 Apr; 16(4):16. PubMed ID: 25796377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
    Gnant M; Mlineritsch B; Stoeger H; Luschin-Ebengreuth G; Heck D; Menzel C; Jakesz R; Seifert M; Hubalek M; Pristauz G; Bauernhofer T; Eidtmann H; Eiermann W; Steger G; Kwasny W; Dubsky P; Hochreiner G; Forsthuber EP; Fesl C; Greil R;
    Lancet Oncol; 2011 Jul; 12(7):631-41. PubMed ID: 21641868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into endocrine therapy for young women with breast cancer.
    Di Lascio S; Pagani O
    Womens Health (Lond); 2015 Jun; 11(3):343-54. PubMed ID: 26102472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant endocrine treatment in premenopausal early breast cancer.
    Orlando L; Fedele P; Cinefra M; Sponziello F; Calvani N; Chetrì MC; Rizzo P; D'Amico M; Schiavone P; Portaluri M; Criscuolo M; Burlizzi S; Cinieri S
    Oncology; 2009; 77 Suppl 1():9-13. PubMed ID: 20130426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Who should not undergo breast conservation?
    Nijenhuis MV; Rutgers EJ
    Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer in women under 40.
    Peppercorn J
    Oncology (Williston Park); 2009 May; 23(6):465-74. PubMed ID: 19544685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized adjuvant therapies: lessons from the past: the opening address by the St. Gallen 2013 award recipient.
    Goldhirsch A
    Breast; 2013 Aug; 22 Suppl 2():S3-7. PubMed ID: 24074788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer in older women.
    Muss HB
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):82-8. PubMed ID: 8614851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian suppression/ablation in premenopausal ER-positive breast cancer patients. Issues and recommendations.
    Pritchard KI
    Oncology (Williston Park); 2009 Jan; 23(1):27-33. PubMed ID: 19283918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ovarian ablation in the management of breast cancer.
    Wirk B
    Breast J; 2005; 11(6):416-24. PubMed ID: 16297086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.